Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Unaudited Financial Results for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hamps Bio Ltd has informed BSE that its Board of Directors will meet on Thursday, November 13, 2025 at the company's corporate office. The main item on the agenda is to consider and approve the Unaudited Financial Results for the half year ended September 30, 2025. The notice is filed in compliance with SEBI LODR Regulation 29. Any other business may be taken up with the Chair's permission. No financial figures, projections, or commentary are included in this filing.
This is a routine pre-results intimation and is not material on its own. Shareholders should watch for the actual unaudited H2 results on or after November 13, 2025 to gauge the company's performance, but the stock is unlikely to move meaningfully on this notice alone.